| __timestamp | HUTCHMED (China) Limited | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 19764000 | 1162636000 |
| Thursday, January 1, 2015 | 67426000 | 1396725000 |
| Friday, January 1, 2016 | 59752000 | 1526100000 |
| Sunday, January 1, 2017 | 65383000 | 1619600000 |
| Monday, January 1, 2018 | 70165000 | 1429100000 |
| Tuesday, January 1, 2019 | 44738000 | 1331200000 |
| Wednesday, January 1, 2020 | 39457000 | 1375200000 |
| Friday, January 1, 2021 | 97894000 | 1563000000 |
| Saturday, January 1, 2022 | 115306000 | 1789600000 |
| Sunday, January 1, 2023 | 453552000 | 2070000000 |
Cracking the code
In the dynamic world of pharmaceuticals, United Therapeutics Corporation and HUTCHMED (China) Limited have showcased intriguing financial trajectories over the past decade. From 2014 to 2023, United Therapeutics consistently outperformed, with gross profits soaring by nearly 78%, peaking at approximately $2.07 billion in 2023. This growth underscores their robust market strategies and innovative product lines.
Conversely, HUTCHMED's journey reflects a more volatile path. Despite a modest start in 2014, their gross profit surged by over 2,000% by 2023, reaching around $453 million. This remarkable growth highlights their expanding footprint in the global market, driven by strategic partnerships and a diversified portfolio.
These trends not only reflect the companies' individual strategies but also the broader shifts in the pharmaceutical landscape, where innovation and adaptability are key to sustained success.
Gross Profit Comparison: Eli Lilly and Company and United Therapeutics Corporation Trends
Bristol-Myers Squibb Company vs United Therapeutics Corporation: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: GSK plc vs United Therapeutics Corporation
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or United Therapeutics Corporation
Biogen Inc. and United Therapeutics Corporation: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? United Therapeutics Corporation or Genmab A/S
United Therapeutics Corporation vs HUTCHMED (China) Limited: Strategic Focus on R&D Spending
United Therapeutics Corporation vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Gross Profit Comparison: Vericel Corporation and HUTCHMED (China) Limited Trends
Who Generates Higher Gross Profit? HUTCHMED (China) Limited or Ligand Pharmaceuticals Incorporated